Literature DB >> 22826871

Case study: to-BBB's G-Technology, getting the best from drug-delivery research with industry-academia partnerships.

Pieter J Gaillard1.   

Abstract

To-BBB aims to develop efficacious treatments for patients with devastating neurological conditions based on to-BBB's proprietary G-Technology that safely enhances the delivery of drugs across the blood-brain barrier. Through strategic research collaborations, a small company such as to-BBB is able to deliver the high-quality research necessary to develop these novel treatments.

Entities:  

Mesh:

Year:  2011        PMID: 22826871     DOI: 10.4155/tde.11.111

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  2 in total

1.  Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal doxorubicin for brain drug delivery with a post-insertion approach.

Authors:  Amin Mehrabian; Roghayyeh Vakili-Ghartavol; Mohammad Mashreghi; Sara Shokooh Saremi; Ali Badiee; Leila Arabi; Seyedeh Hoda Alavizadeh; Seyedeh Alia Moosavian; Mahmoud Reza Jaafari
Journal:  Iran J Basic Med Sci       Date:  2022-03       Impact factor: 2.532

Review 2.  Nanocarriers Call the Last Shot in the Treatment of Brain Cancers.

Authors:  Amin Mehrabian; Mohammad Mashreghi; Saba Dadpour; Ali Badiee; Leila Arabi; Seyedeh Hoda Alavizadeh; Seyedeh Alia Moosavian; Mahmoud Reza Jaafari
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.